Company News: StrikeForce Communications and Makovsky + Co.

Share this article:
Alcon has awarded two accounts to StrikeForce Communications, including global strategic and creative responsibilities for I-Caps, a line of ocular nutrition products aimed at delaying the progress of age related macular degeneration, and for OTC dry eye therapy Systane. The New York-based shop also recently won an assignment for Orexigen Theraeutics' obesity drug, which is under FDA review.

Makovsky + Company has been retained by Neoprobe Corp., for its strategic communications and investor relations program as the Dublin, Ohio-based firm, which makes surgical oncology products, prepares for the commercialization of Lymphoseek and the launch of a RIGS clinical development program.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.